A detailed history of Great West Life Assurance CO transactions in Mannkind Corp stock. As of the latest transaction made, Great West Life Assurance CO holds 106,547 shares of MNKD stock, worth $698,948. This represents 0.0% of its overall portfolio holdings.

Number of Shares
106,547
Previous 124,994 14.76%
Holding current value
$698,948
Previous $564,000 1.42%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$4.05 - $5.43 $74,710 - $100,167
-18,447 Reduced 14.76%
106,547 $556,000
Q4 2023

Feb 13, 2024

BUY
$3.34 - $4.29 $70,654 - $90,750
21,154 Added 20.37%
124,994 $452,000
Q3 2023

Nov 14, 2023

BUY
$3.91 - $5.45 $102,461 - $142,817
26,205 Added 33.75%
103,840 $428,000
Q2 2023

Aug 10, 2023

BUY
$3.72 - $4.79 $242,648 - $312,442
65,228 Added 525.74%
77,635 $317,000
Q3 2022

Nov 01, 2022

BUY
$2.99 - $4.35 $37,096 - $53,970
12,407 New
12,407 $38,000
Q2 2021

Aug 11, 2021

BUY
$3.61 - $5.45 $44,789 - $67,618
12,407 New
12,407 $67,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.69B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.